Start the conversation
It will certainly go down as one of the strongest business alliances in the history of technology - and one of the most profitable as well...
At their peak, these two companies dominated the personal-computing market, accounting for roughly 95% of sales.
As a result of their unique fit, both companies made thousands of shareholders rich.
No doubt, in recent years both these firms failed to keep up with rapid changes in the global tech landscape. And their shareholders paid the price as both stocks lagged the tech sector and the overall market.
It's been more than a decade since these firms' heyday, but now both stocks have beaten the odds - and are back at trouncing the Standard & Poor's 500.
This lands both companies squarely on our best tech stocks to buy list - here's why...
Wintel's Rise... and Fall
You'd be hard-pressed to find a stock that beat Microsoft Corp. (Nasdaq: MSFT) during its halcyon days. From its initial public offering in March 1986 to its peak in January 2000, Microsoft stock rose an astounding 25,000%.
That wealth machine would have converted $10,000 into $2.5 million in just under 15 years.
The Redmond, Wash.-based firm was so successful because it made the operating system used by virtually every PC manufacturer, besides Apple Inc. (Nasdaq: AAPL).
And, in turn, 90% of those PCs relied on semiconductors made by Intel Corp. (Nasdaq: INTC).
The technology media dubbed this unbeatable team "Wintel" to describe PCs' standard configuration - the Microsoft Windows OS and Intel chips.
The matchup was great for Intel shareholders, too. During Microsoft's great run, Intel shares rose 5,550%. Both stocks simply crushed the S&P 500, which produced gains of 565% during the period.
On the one hand, Wintel's outstanding performance is just one of many examples of how "the road to wealth is paved by tech."
On the other hand, the Wintel saga shows what can happen to market leaders who fail to keep up with big shifts in technology.
The slowing growth rate in the PC market that followed the "dot-bomb" implosion of 2000 ended the years of eye-popping increases for Wintel. The decade that followed taught Microsoft and Intel investors a very hard lesson: The market doesn't reward companies that rake in profits but show only modest rates of growth.
And in more recent years, neither Microsoft nor Intel have made solid entries into either cloud computing or the mobile revolution.
Over the past five years, the tech-centric Nasdaq Composite Index has gained 126%, compared with 83% for Microsoft and 76% for Intel.
Clearly, a shake-up at the top was in order to reverse course for both companies...
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.